Compatibility & Incompatibility
KENGREAL® (cangrelor) should be administered via a dedicated IV line.1
Physical compatibility studies using a simulated Y-site have been conducted with KENGREAL®, diluted in 0.9% sodium chloride and commonly used IV products, including those likely for coadministration during PCI. The following products were physically compatible after four hours.1,2
Compatibility studies have been conducted with commonly used IV products, including those likely for coadministration during PCI. Although the list below is not comprehensive, the following products should NOT be used with KENGREAL® in either an IV line or via a Y-site.
*Tested undiluted (not diluted in 0.9% sodium chloride or 5% dextrose injection).
HCL=hydrochloride; mcg=microgram; mg=milligram; mL=milliliter
References: 1. KENGREAL® (cangrelor) Prescribing Information. 2016. 2. Data on file, Chiesi USA, Inc.